Randomized controlled trials are also needed to determine whether statins can actually reduce the risk for hepatocellular ...

Patients with MASLD had nearly twice the all-cause mortality rate as the general population, suggesting the need for ...

People who used lipophilic (fat-soluble) statins like atorvastatin and simvastatin had the greatest outcomes and ...

Liver TET1 was found to promote metabolic dysfunction-associated steatotic liver disease (MASLD) by regulating CD36 ...

Research published in JAMA Internal Medicine reveals statins may reduce liver cancer risk by 33% and liver complications by ...

Harvard Medical School researchers have found that statin use significantly reduces the risk of hepatocellular carcinoma (HCC ...

The below brands have announced their latest funding rounds, securing fresh capital to drive expansion and innovation.

Katie Thurston has shared an update after revealing earlier this month that she was diagnosed with breast cancer. The former ...

Tvaster Genkalp secured $1.25 million in pre-series A funding led by Ideaspring Capital to expand Episcreen Liver, a non-invasive liquid biopsy for early liver cancer detection with 90% sensitivity.

Liver cancer, predominantly hepatocellular carcinoma (HCC), remains one of the most aggressive and leading causes of ...

Broaden inclusion in research and guidelines. Regulatory agencies and funding bodies should require adequate representation ...

Carcinoma is a type of cancer that starts in cells that make up the skin or the tissue lining organs, such as the liver or kidneys. Like other types of cancer, carcinomas are abnormal cells that ...